3α,5α-Dihydrolevonorgestrel

A synthetic progestogen and active metabolite of levonorgestrel

3α,5α-Dihydrolevonorgestrel is a synthetic progestogen and an active metabolite of the widely used contraceptive drug levonorgestrel. It is part of the class of compounds known as 19-norprogesterone derivatives, which are characterized by the removal of the 19-methyl group from the progesterone structure.

Chemical Structure and Properties

3α,5α-Dihydrolevonorgestrel is a steroid with the chemical formula C₁₉H₂₆O₂. It is a derivative of levonorgestrel, which is a synthetic progestogen used in various hormonal contraceptives. The compound is characterized by its 3α,5α-dihydro configuration, which refers to the specific stereochemistry of the hydrogen atoms at the 3rd and 5th positions of the steroid nucleus.

Pharmacology

As an active metabolite of levonorgestrel, 3α,5α-Dihydrolevonorgestrel contributes to the overall progestogenic activity of the parent compound. It binds to the progesterone receptor with high affinity, exerting effects that include the suppression of ovulation, thickening of the cervical mucus, and alteration of the endometrium to prevent implantation of a fertilized egg.

Metabolism

Levonorgestrel undergoes extensive hepatic metabolism in the liver, where it is reduced to several metabolites, including 3α,5α-Dihydrolevonorgestrel. This reduction is catalyzed by the enzyme 5α-reductase, which is also involved in the metabolism of other steroid hormones such as testosterone.

Clinical Significance

The presence of 3α,5α-Dihydrolevonorgestrel as a metabolite is significant in understanding the pharmacokinetics and pharmacodynamics of levonorgestrel. Its activity contributes to the efficacy of levonorgestrel-containing contraceptives, which are used in various forms such as oral pills, intrauterine devices (IUDs), and emergency contraception.

Research and Development

Research into the specific roles and effects of 3α,5α-Dihydrolevonorgestrel is ongoing, with studies focusing on its receptor binding characteristics, metabolic pathways, and potential therapeutic applications beyond contraception.

Also see

• Levonorgestrel
• Progestogen
• Hormonal contraception
• 5α-Reductase
• Metabolite